The contaminated fentanyl case escalated politically again after one of the detained former officials implicated Health Minister Mario Lugones. Her statement introduced a phrase with strong institutional weight: according to that version, decisions were made after consulting the minister.
The allegation comes within an investigation that had already shaken the health system over the commercialization of contaminated ampoules that reached hospitals, clinics and sanatoriums. The case examines responsibility for control failures over critical-use medicines and for the circulation of products that should never have entered the market.
The detainees are Nélida Bisio, a former ANMAT authority, and Gabriela Fumadó, who headed the National Institute of Medicines. Both are under scrutiny for the role they played in regulatory controls over laboratories and medicinal products, a key function when high-risk drugs are involved.
This new chapter shifts the focus from technical responsibility to the political chain of decision-making. If sensitive measures were subject to ministerial consultation, the investigation may move further into how alerts, inspections, delays and administrative decisions were communicated inside the Health Ministry.
The case also reopens the debate over the state's capacity to supervise laboratories, respond to quality deviations and remove dangerous medicines from circulation. In a health tragedy linked to dozens of deaths, every administrative delay takes on a different weight and can become judicial material.
For the Government, the issue is no longer limited to explaining what failed inside ANMAT or INAME. The statement pointing to Lugones raises a broader question: how far the information reached within the political leadership of Health and what decisions were made while the contaminated fentanyl remained under investigation.
